The global orthopedic oncology treatment market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing number of cancer cases and rise in awareness about cancer treatments. The global orthopedic oncology treatment market is segmented by type, application, and region. Soft tissue excisions/resections are expected to account for the largest share in the global orthopedic oncology treatment market during the forecast period due to their high prevalence among patients with bone tumors. Limb salvage surgery is also expected to account for a significant share in this market due to its ability to preserve limb function and improve quality of life among patients with bone tumors. North America accounted for the largest share in this market owing primarily due to its large population base and high healthcare expenditure per capita as compared with other regions such as Asia Pacific and Latin America.
-The Orthopedic Oncology Treatment market is expected to grow at a CAGR of 5.5% from 2017 to 2022.
-The Orthopedic Oncology Treatment market is driven by the increasing incidence of cancer, rising awareness about the benefits of orthopedic oncology treatment, and technological advancements in orthopedics.
-Increasing incidence of cancer: The incidence rate for cancer has been increasing over the years and it is estimated that there will be an increase in the number of people diagnosed with cancer every year. This will lead to an increase in demand for orthopedic oncology treatment services as well as drugs used for this purpose -Rising awareness about benefits: Awareness about the benefits associated with orthopedic oncology treatment has been increasing over time which leads to more people seeking out these treatments and drugs. This also leads to increased demand for these products which drives up revenue growth rates in this industry segment -Technological advancements: Technological advancements have led to better diagnostic tools and improved surgical techniques which have helped improve patient outcomes while reducing complications associated with surgery or chemotherapy treatments. These improvements are driving up demand for these products as well as driving down costs due to reduced complications rates which increases revenue growth rates in this industry segment.
Industry Growth Insights published a new data on “Orthopedic Oncology Treatment Market”. The research report is titled “Orthopedic Oncology Treatment Market research by Types (Soft Tissue Excisions/Resections, Limb Salvage Surgery, Amputation, Adjuvant Chemotherapy, Reconstructive Surgery), By Applications (Hospitals, Clinic, Others), By Players/Companies Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew plc, DePuy Synthes (Johnson & Johnson), Medtronic, Accentus Medical, Roche Holding AG, Amgen, Inc., Novartis AG, GlaxoSmithKline, Sanofi, Pfizer Inc.”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Orthopedic Oncology Treatment Market Research Report
By Type
Soft Tissue Excisions/Resections, Limb Salvage Surgery, Amputation, Adjuvant Chemotherapy, Reconstructive Surgery
By Application
Hospitals, Clinic, Others
By Companies
Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew plc, DePuy Synthes (Johnson & Johnson), Medtronic, Accentus Medical, Roche Holding AG, Amgen, Inc., Novartis AG, GlaxoSmithKline, Sanofi, Pfizer Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Orthopedic Oncology Treatment Market Report Segments:
The global Orthopedic Oncology Treatment market is segmented on the basis of:
Types
Soft Tissue Excisions/Resections, Limb Salvage Surgery, Amputation, Adjuvant Chemotherapy, Reconstructive Surgery
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Stryker Corporation
- Zimmer Biomet Holdings, Inc.
- Smith & Nephew plc
- DePuy Synthes (Johnson & Johnson)
- Medtronic
- Accentus Medical
- Roche Holding AG
- Amgen, Inc.
- Novartis AG
- GlaxoSmithKline
- Sanofi
- Pfizer Inc.
Highlights of The Orthopedic Oncology Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Soft Tissue Excisions/Resections
- Limb Salvage Surgery
- Amputation
- Adjuvant Chemotherapy
- Reconstructive Surgery
- By Application:
- Hospitals
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Orthopedic Oncology Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Orthopedic oncology is a specialty of cancer treatment that focuses on the prevention, diagnosis and treatment of diseases and conditions related to the bones and joints.
Some of the major companies in the orthopedic oncology treatment market are Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew plc, DePuy Synthes (Johnson & Johnson), Medtronic, Accentus Medical, Roche Holding AG, Amgen, Inc., Novartis AG, GlaxoSmithKline, Sanofi, Pfizer Inc..
The orthopedic oncology treatment market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Orthopedic Oncology Treatment Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Orthopedic Oncology Treatment Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Orthopedic Oncology Treatment Market - Supply Chain
4.5. Global Orthopedic Oncology Treatment Market Forecast
4.5.1. Orthopedic Oncology Treatment Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Orthopedic Oncology Treatment Market Size (000 Units) and Y-o-Y Growth
4.5.3. Orthopedic Oncology Treatment Market Absolute $ Opportunity
5. Global Orthopedic Oncology Treatment Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Orthopedic Oncology Treatment Market Size and Volume Forecast by Type
5.3.1. Soft Tissue Excisions/Resections
5.3.2. Limb Salvage Surgery
5.3.3. Amputation
5.3.4. Adjuvant Chemotherapy
5.3.5. Reconstructive Surgery
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Orthopedic Oncology Treatment Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Orthopedic Oncology Treatment Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinic
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Orthopedic Oncology Treatment Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Orthopedic Oncology Treatment Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Orthopedic Oncology Treatment Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Orthopedic Oncology Treatment Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Orthopedic Oncology Treatment Demand Share Forecast, 2019-2026
9. North America Orthopedic Oncology Treatment Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Orthopedic Oncology Treatment Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Orthopedic Oncology Treatment Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinic
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Orthopedic Oncology Treatment Market Size and Volume Forecast by Type
9.7.1. Soft Tissue Excisions/Resections
9.7.2. Limb Salvage Surgery
9.7.3. Amputation
9.7.4. Adjuvant Chemotherapy
9.7.5. Reconstructive Surgery
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Orthopedic Oncology Treatment Demand Share Forecast, 2019-2026
10. Latin America Orthopedic Oncology Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Orthopedic Oncology Treatment Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Orthopedic Oncology Treatment Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinic
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Orthopedic Oncology Treatment Market Size and Volume Forecast by Type
10.7.1. Soft Tissue Excisions/Resections
10.7.2. Limb Salvage Surgery
10.7.3. Amputation
10.7.4. Adjuvant Chemotherapy
10.7.5. Reconstructive Surgery
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Orthopedic Oncology Treatment Demand Share Forecast, 2019-2026
11. Europe Orthopedic Oncology Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Orthopedic Oncology Treatment Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Orthopedic Oncology Treatment Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinic
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Orthopedic Oncology Treatment Market Size and Volume Forecast by Type
11.7.1. Soft Tissue Excisions/Resections
11.7.2. Limb Salvage Surgery
11.7.3. Amputation
11.7.4. Adjuvant Chmotherapy
11.7.5. Reconstructive Surgery
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Orthopedic Oncology Treatment Demand Share, 2019-2026
12. Asia Pacific Orthopedic Oncology Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Orthopedic Oncology Treatment Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Orthopedic Oncology Treatment Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinic
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Orthopedic Oncology Treatment Market Size and Volume Forecast by Type
12.7.1. Soft Tissue Excisions/Resections
12.7.2. Limb Salvage Surgery
12.7.3. Amputation
12.7.4. Adjuvant Chemotherapy
12.7.5. Reconstructive Surgery
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Orthopedic Oncology Treatment Demand Share, 2019-2026
13. Middle East & Africa Orthopedic Oncology Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Orthopedic Oncology Treatment Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Orthopedic Oncology Treatment Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinic
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Orthopedic Oncology Treatment Market Size and Volume Forecast by Type
13.7.1. Soft Tissue Excisions/Resections
13.7.2. Limb Salvage Surgery
13.7.3. Amputation
13.7.4. Adjuvant Chemotherapy
13.7.5. Reconstructive Surgery
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Orthopedic Oncology Treatment Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Orthopedic Oncology Treatment Market: Market Share Analysis
14.2. Orthopedic Oncology Treatment Distributors and Customers
14.3. Orthopedic Oncology Treatment Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Stryker Corporation
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Zimmer Biomet Holdings, Inc.
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Smith & Nephew plc
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. DePuy Synthes (Johnson & Johnson)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Medtronic
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Accentus Medical
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Roche Holding AG
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Amgen, Inc.
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Novartis AG
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. GlaxoSmithKline
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Sanofi
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Pfizer Inc.
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
